GI Bleeding Risk of DOACs Versus Warfarin: Is Newer Better?

Dig Dis Sci. 2018 Jul;63(7):1675-1677. doi: 10.1007/s10620-018-5060-1.

Authors

Linda A Feagins^{1

2}, Rick A Weideman³

Affiliations

¹ Division of Gastroenterology and Hepatology, VA North Texas Healthcare System, 4500 S. Lancaster Rd 111B1, Dallas, TX, 75216, USA. Linda.Feagins@UTSouthwestern.edu.
² Division of Gastroenterology and Hepatology, UT Southwestern Medical Center, Dallas, TX, USA. Linda.Feagins@UTSouthwestern.edu.
³ Department of Pharmacy, VA North Texas Healthcare System, Dallas, TX, USA.

PMID: 29671162
DOI: 10.1007/s10620-018-5060-1

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants*
Gastrointestinal Hemorrhage
Humans
Risk
Warfarin*

Substances

Anticoagulants
Warfarin